Molsentech owns advanced semiconductor biochip, biological signal reading, high-throughput data analysis and other cross-field integration technologies, to develops non-invasive biochips that can be detected in real time, and provides emerging products with high sensitivity in the global detection market.The company was established in 2014. The core team comes from the Institute of Physics, Academia Sinica. It is the first team to invest in biological nano-component research in Taiwan, with more than 20 years of research and development experience. Molsentech adheres to the concept of innovation and integration, links the industry chain, and creates a semiconductor biochip industry ecosystem, deploys smart medical care, and will implement precision medicine in the future to become everyone's health guardian.